�������ýҕ�l

A nursing strike that disrupted patient care at two of New York City's largest hospitals for three days is over. (1/12)

Nearly 1 in 4 patients who are admitted to hospitals in the U.S. will experience harm, according to a study published Wednesday in the New England Journal of Medicine. (Sullivan, 1/11)

A physicians group is urging the Food and Drug Administration to hold an expert panel meeting to review an experimental Alzheimer’s treatment before issuing a full-blown approval, a move that reflects nagging safety issues surrounding the medication. (Silverman, 1/11)

A $50 million donation from the Cummings Foundation will create the Paul Farmer Collaborative, an international partnership between Harvard Medical School and the University of Global Health Equity, a health sciences school in Rwanda co-founded by Dr. Paul Farmer, the late global health champion. (Mohammed, 1/11)

Decoding the billions of chemical letters that help shape who we are once cost a fortune. But genomics startup Element Biosciences on Wednesday announced it can now read a whole human genome for as little as $200 — the cost of a couple trips to the grocery store. (Wosen, 1/11)

Ready or not, health care is undergoing a massive transformation driven by artificial intelligence. But medical schools have barely started to teach about AI and machine learning — creating knowledge gaps that could compound the damage caused by flawed algorithms and biased decision-support systems. (Palmer, 1/12)

When BioNTech was founded in 2008, messenger RNA therapies and vaccines were still an unproven idea. The German company has now shipped out billions of doses of its mRNA Covid-19 vaccine worldwide — and BioNTech’s leaders say that’s just the beginning of a larger revolution in medicine. (Wosen, 1/12)

Startup insurers Oscar Health, Bright Health, and Clover Health have hemorrhaged money since going public within the past two years. All three used their stage time at the J.P. Morgan Healthcare Conference to make the case that their drastic decisions — like fully exiting some insurance markets — will deliver the profitability investors are demanding. (Bannow and Herman, 1/11)

Nonprofit healthcare systems are in for a tough year, but a Fitch Ratings report released Wednesday projects even the hardest-hit providers may start to see improvement in the coming months. (Hudson, 1/11)

Verily Life Sciences, a healthcare unit of Alphabet Inc. is laying off more than 200 employees as part of a broader reorganization, the first major staff reductions to hit Google’s parent following a wave of layoffs at other technology companies. (Kruppa, 1/11)

Billionaire entrepreneur Mark Cuban's pharmaceuticals startup has tied up with pharmacy benefits manager RxPreferred Benefits, the companies said on Wednesday, in a move to offer lower priced drugs through some employer-backed health insurance plans. (1/11)

The law prohibits flavors, odors or “tastes” in tobacco products, including menthol cigarettes. But antismoking experts argue that R.J. Reynolds, the maker of Camel and Newport brands, is trying to circumvent the ban by luring smokers with a suite of what it says are new non-menthol versions offering “a taste that satisfies the senses” and “a new fresh twist.” (Jewett and Baumgaertner, 1/11)

A U.S. judge ruled that Apple (AAPL.O) had infringed on one of Masimo Corp's (MASI.O) pulse oximeter patents by importing and selling certain Apple Watches with light-based pulse oximetry functionality and components, Masimo said on Tuesday. The United States International Trade Commission (USITC) will now consider whether to implement an import ban on these Apple Watches, the medical device maker said. (1/11)